135 related articles for article (PubMed ID: 2117064)
1. Response of A431 experimental human solid xenograft to mitomycin C in combination with human epidermal growth factor in mice.
Amagase H; Tamura K; Hashimoto K; Fuwa T; Murakami T; Yata N
J Pharmacobiodyn; 1990 Apr; 13(4):263-8. PubMed ID: 2117064
[TBL] [Abstract][Full Text] [Related]
2. Mitomycin C combination therapy against murine tumor systems. Effectiveness with cyclophosphamide and methotrexate.
Mabel JA; Wodinsky I
Cancer; 1983 Feb; 51(4):600-5. PubMed ID: 6401590
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor-mediated selective cytotoxicity of antitumor agents toward human xenografts and murine syngeneic solid tumors.
Amagase H; Kakimoto M; Hashimoto K; Fuwa T; Tsukagoshi S
Jpn J Cancer Res; 1989 Jul; 80(7):670-8. PubMed ID: 2507490
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of antitumor activity of mitomycin C in vitro and in vivo by UCN-01, a selective inhibitor of protein kinase C.
Akinaga S; Nomura K; Gomi K; Okabe M
Cancer Chemother Pharmacol; 1993; 32(3):183-9. PubMed ID: 8500222
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of 7-N-[[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]]-mitomycin C.
Morimoto M; Ashizawa T; Ohno H; Azuma M; Kobayashi E; Okabe M; Gomi K; Kono M; Saitoh Y; Kanda Y
Cancer Res; 1991 Jan; 51(1):110-5. PubMed ID: 1988076
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with vascular endothelial growth factor neutralizing antibody and mitomycin C on human gastric cancer xenograft.
Matsumoto K; Konno H; Tanaka T; Baba M; Kanai T; Kamiya K; Ohba K; Nakamura S
Jpn J Cancer Res; 2000 Jul; 91(7):748-52. PubMed ID: 10920283
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of mitomycin C-dextran conjugate against various murine tumors.
Hashida M; Kato A; Kojima T; Muranishi S; Sezaki H; Tanigawa N; Satomura K; Hikasa Y
Gan; 1981 Apr; 72(2):226-34. PubMed ID: 6169584
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of a derivative of mitomycin, 7-N-[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]mitomycin C (KW-2149), against murine and human tumors and a mitomycin C-resistant tumor in vitro and in vivo.
Tsuruo T; Sudo Y; Asami N; Inaba M; Morimoto M
Cancer Chemother Pharmacol; 1990; 27(2):89-93. PubMed ID: 2123421
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
Chen P; Cameron R; Wang J; Vallis KA; Reilly RM
J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effects of two polyamine antimetabolites combined with mitomycin C on human stomach cancer cells xenotransplanted into nude mice.
Fujimoto S; Igarashi K; Shrestha RD; Miyazaki M; Okui K
Int J Cancer; 1985 Jun; 35(6):821-5. PubMed ID: 3924844
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity and toxicity in animals of N-7[2-(4-nitrophenyldithio) ethyl] mitomycin C (BMY-25067).
Bradner WT; Rose WC; Schurig JE; Florczyk AP
Invest New Drugs; 1990; 8 Suppl 1():S1-7. PubMed ID: 2380013
[TBL] [Abstract][Full Text] [Related]
12. [Antitumor efficacy of polyamine antimetabolites and mitomycin C under polyamine-free diet].
Fujimoto S; Shrestha RD; Ohta M; Igarashi K; Kokubun M; Okui K; Fujita M; Taguchi T
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2930-5. PubMed ID: 3116945
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human tumor xenograft growth in nude mice by a conjugate of monoclonal antibody LA22 to epidermal growth factor receptor with anti-tumor antibiotics mitomycin C.
Shao W; Zhao S; Liu Z; Zhang J; Ma S; Sato JD; Zhang P; Tong M; Han J; Wang Y; Bai D; Wang F; Sun L
Biochem Biophys Res Commun; 2006 Oct; 349(2):816-24. PubMed ID: 16950201
[TBL] [Abstract][Full Text] [Related]
14. Effects of BMY 25282, a mitomycin C analogue, in mitomycin C-resistant human colon cancer cells.
Willson JK; Long BH; Chakrabarty S; Brattain DE; Brattain MG
Cancer Res; 1985 Nov; 45(11 Pt 1):5281-6. PubMed ID: 3931904
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of 7-n-(p-hydroxyphenyl)-mitomycin C in experimental tumor systems.
Imai R; Morimoto M; Marumo H; Kobayashi T; Tsuruo T; Inaba M; Tsukagoshi S; Sakurai Y
Gan; 1981 Dec; 72(6):944-9. PubMed ID: 6804296
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor prolongs survival time of tumor-bearing mice.
Amagase H; Tamura K; Okuhira M; Kakimoto M; Amano H; Hashimoto K; Fuwa T; Tsukagoshi S
Jpn J Cancer Res; 1990 May; 81(5):495-500. PubMed ID: 2116398
[TBL] [Abstract][Full Text] [Related]
17. [Studies on biodegradable microspheres containing mitomycin C].
Fujimoto S; Endoh F; Kitsukawa Y; Morimoto Y; Sugibayashi K; Okui K
Gan To Kagaku Ryoho; 1983 May; 10(5):1328-33. PubMed ID: 6409003
[TBL] [Abstract][Full Text] [Related]
18. [Experimental studies on antitumor effects of lysozyme].
Fukawa K; Nishimura N; Irino O; Nakazato K; Taguchi A; Nitta K
Gan To Kagaku Ryoho; 1982 May; 9(5):915-23. PubMed ID: 7184434
[TBL] [Abstract][Full Text] [Related]
19. Cellular interaction and in vitro antitumor activity of mitomycin C-dextran conjugate.
Matsumoto S; Yamamoto A; Takakura Y; Hashida M; Tanigawa N; Sezaki H
Cancer Res; 1986 Sep; 46(9):4463-8. PubMed ID: 2425952
[TBL] [Abstract][Full Text] [Related]
20. [Effect of mitomycin C on human gastric and colon carcinomas serially transplanted to nude mice--with special reference to the start of drug administration].
Kubota T; Hanatani Y; Tsuyuki K; Nakada M; Asanuma F; Ishibiki K; Abe O
Gan To Kagaku Ryoho; 1982 Apr; 9(4):638-45. PubMed ID: 6820902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
